NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

COR

Cencora Inc

May 23 • 04:00PM ET

292.35

Dollar change +2.24
Percentage change 0.77	%

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC OMI PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO SPY IVV VTV XLV VOE IWP VIG

Scroll to Statements

Index	S&P 500	P/E	33.93	EPS (ttm)	8.62	Insider Own	5.73%	Shs Outstand	193.78M	Perf Week	0.73%
Market Cap	56.66B	Forward P/E	16.91	EPS next Y	17.28	Insider Trans	-11.42%	Shs Float	182.71M	Perf Month	3.53%
Income	1.69B	PEG	2.96	EPS next Q	3.82	Inst Own	93.60%	Short Float	3.63%	Perf Quarter	19.70%
Sales	310.23B	P/S	0.18	EPS this Y	14.63%	Inst Trans	1.41%	Short Ratio	3.54	Perf Half Y	21.32%
Book/sh	5.23	P/B	55.93	EPS next Y	9.58%	ROA	2.51%	Short Interest	6.63M	Perf Year	34.67%
Cash/sh	10.89	P/C	26.85	EPS next 5Y	11.48%	ROE	161.58%	52W Range	214.77 - 309.35	Perf YTD	30.12%
Dividend Est.	2.20 (0.75%)	P/FCF	15.85	EPS past 5Y	13.29%	ROI	20.91%	52W High	-5.50%	Beta	0.58
Dividend TTM	2.16 (0.74%)	Quick Ratio	0.52	Sales past 5Y	10.39%	Gross Margin	2.94%	52W Low	36.12%	ATR (14)	6.37
Dividend Ex-Date	May 16, 2025	Current Ratio	0.87	EPS Y/Y TTM	-5.92%	Oper. Margin	1.03%	RSI (14)	57.27	Volatility	0.60% 2.14%
Employees	46000	Debt/Eq	7.76	Sales Y/Y TTM	12.18%	Profit Margin	0.55%	Recom	1.82	Target Price	330.00
Option/Short	Yes / Yes	LT Debt/Eq	7.00	EPS Q/Q	75.92%	Payout	27.07%	Rel Volume	0.73	Prev Close	290.11
Sales Surprise	-0.24%	EPS Surprise	7.42%	Sales Q/Q	10.29%	Earnings	May 07 BMO	Avg Volume	1.87M	Price	292.35
SMA20	1.17%	SMA50	3.89%	SMA200	17.15%	Trades		Volume	1,356,426	Change	0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Jun-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$112
Apr-23-20	Resumed	Credit Suisse	Outperform	$105
Apr-01-20	Upgrade	JP Morgan	Neutral → Overweight	$93 → $106
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform	$112

Show Previous Ratings

May-23-25 04:03PM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
10:47AM	RVTY Stock Falls Despite the Latest Launch of Automated Instrument (Zacks)
06:20AM	Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar? (Zacks)
May-22-25 09:54AM	Here's Why Investors Should Consider Retaining Danaher Stock Now (Zacks)
06:20AM	Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? (Zacks)
01:08PM	Loading…
May-21-25 01:08PM	MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio (Zacks)
07:17AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio (Zacks)
06:20AM	Is Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) a Strong ETF Right Now? (Zacks)
May-19-25 09:58AM	Robust Results Lifted Cencora (COR) Amid Upgraded Outlook (Insider Monkey)
07:02AM	Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now (Zacks)
06:54AM	MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now? (Zacks)
May-18-25 06:56AM	Jim Cramer Highlights Cencora (COR) "Knocked It Out of The Park" (Insider Monkey)
May-16-25 08:00AM	Here's Why You Should Add DexCom Stock to Your Portfolio Now (Zacks)
07:59AM	Doximity Stock Plunges Despite Q4 Earnings & Sales Beat, Margins Up (Zacks)
06:20AM	Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? (Zacks)
06:20AM	Loading…
May-14-25 06:20AM	Should Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) Be on Your Investing Radar? (Zacks)
May-12-25 08:01AM	Beat the Market the Zacks Way: Limbach, Stride, Cencora in Focus (Zacks)
May-09-25 09:50AM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
May-08-25 05:05PM	S&P 500 Gains and Losses Today: Axon Enterprise Soars as Software Demand Drives Earnings Beat (Investopedia) -6.83%
09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
May-07-25 05:00PM	Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
03:40PM	Analyst Report: Cencora, Inc. (Morningstar Research)
01:25PM	Jim Cramer on Cencora, Inc. (COR): 'Middleman Money Machine Silences the Doubters' (Insider Monkey)
01:25PM	Jim Cramer on Cencora (COR): "Middleman Money Machine Silences the Doubters" (Insider Monkey)
01:09PM	COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised (Zacks)
10:57AM	Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth (Seeking Alpha)
10:55AM	Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:40AM	Has BrightSpring Health Services, Inc. (BTSG) Outpaced Other Medical Stocks This Year? (Zacks)
07:40AM	Cencora (COR) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:30AM	Cencora Reports Fiscal 2025 Second Quarter Results (Business Wire)
10:13AM	Loading…
May-06-25 10:13AM	MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN (Zacks)
06:20AM	Is First Trust Growth Strength ETF (FTGS) a Strong ETF Right Now? (Zacks)
May-05-25 11:12AM	DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock? (Zacks)
07:25AM	Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates? (Zacks)
May-02-25 09:00PM	LRT Capital Management April 2025 Investor Update (Seeking Alpha)
11:05AM	Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings? (Zacks)
09:15AM	Unveiling Cencora (COR) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-30-25 10:17AM	Will Declining Medical Customers Affect Cigna's Q1 Earnings? (Zacks)
10:01AM	Cencora (COR) Earnings Expected to Grow: Should You Buy? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-28-25 12:23PM	Can Humana Beat Q1 Earnings Estimates on Growing Premiums? (Zacks)
11:22AM	Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings? (Zacks)
09:12AM	Here's How Charles River is Placed Just Ahead of Q1 Earnings (Zacks)
08:45AM	GYN Surgical Division Likely to Drive Hologic's Q2 Earnings (Zacks)
08:08AM	Beat the Market the Zacks Way: ProAssurance, Stride, Hershey in Focus (Zacks)
01:55AM	CHGX: Equal-Weight ESG ETF (Seeking Alpha)
Apr-25-25 08:02AM	Cencora (COR) Surged on Strong Returns (Insider Monkey)
08:00AM	Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely? (Zacks)
Apr-24-25 06:14PM	TimesSquare U.S. Focus Growth Q1 2025 Commentary (Seeking Alpha)
02:50PM	TimesSquare U.S. Mid Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
11:00AM	Universal Health to Report Q1 Earnings: Can it Surprise Wall Street? (Zacks)
Apr-23-25 01:41PM	HCA Healthcare to Report Q1 Earnings: Key Estimates to Note (Zacks)
01:28PM	Can Centene Beat Q1 Earnings Estimates on Growing Premiums? (Zacks)
Apr-22-25 11:30AM	BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care (Zacks)
11:19AM	Molina Healthcare to Report Q1 Earnings: Key Estimates to Watch (Zacks)
Apr-21-25 09:40AM	Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year? (Zacks)
06:20AM	Should First Trust Growth Strength ETF (FTGS) Be on Your Investing Radar? (Zacks)
Apr-17-25 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:52AM	3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes (Zacks)
09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Apr-16-25 12:53PM	Jim Cramer: Cencora (COR) Is a "Must-Own" Drug Middleman - Even If It Should Be Digitized Away (Insider Monkey)
Apr-15-25 02:30AM	FTCS: Unconvincing Quality-Focused ETF (Seeking Alpha)
Apr-14-25 09:48AM	BAX Stock Declines Despite Latest Product Launch Boosting Patient Care (Zacks)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
08:02AM	Beat the Market the Zacks Way: Casey's, Stride, McDonald's in Focus (Zacks)
Apr-13-25 05:43PM	Jim Cramer Likes Cencora (COR) "Middlemen Always Work." (Insider Monkey)
Apr-10-25 09:02AM	Cencora, Inc. (COR): A Bull Case Theory (Insider Monkey)
07:25AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
05:08AM	Medpace (MEDP) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Apr-09-25 08:57AM	Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence (Zacks)
08:00AM	Top 3 S&P 500 Winners in a Losing Market (MarketBeat)
Apr-08-25 12:04PM	ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps (Zacks)
Apr-07-25 07:45AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
Apr-04-25 12:08PM	Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High (Investor's Business Daily)
11:57AM	Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds (Zacks)
08:27AM	4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues (Zacks)
08:06AM	Here's Why You Should Retain DexCom Stock in Your Portfolio for Now (Zacks)
05:14AM	3 Reasons COR Has Explosive Upside Potential (StockStory)
Apr-03-25 03:00PM	MCK Stock Gains as PRISM Acquisition Adds High-Growth Business (Zacks)
09:40AM	Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year? (Zacks)
07:54AM	AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK (Zacks)
Apr-02-25 03:00PM	MIST Stock Falls 66% Following Complete Response Letter for Cardamyst (Zacks)
07:47AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
Apr-01-25 01:23PM	GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm (Zacks)
11:00AM	10 Stocks of the S&P 500 ETF Up More Than 20% in Q1 (Zacks)
08:08AM	Beat the Market the Zacks Way: Amgen, Stride, Sea Limited in Focus (Zacks)
07:21AM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
Mar-31-25 09:45AM	Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:34AM	Jim Cramer on Cencora (COR): "Smart Moves in the Drug Middleman Game!" (Insider Monkey)
Mar-28-25 09:48AM	Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical (Zacks)
09:35AM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
07:00AM	Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release (Business Wire)
Mar-27-25 07:30PM	Analyst Report: Cencora, Inc. (Morningstar Research)
01:15PM	3 Medical Services Industry Stocks to Buy as AI Fuels Growth (Zacks)
09:40AM	Cencora (COR) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
09:15AM	Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? (Zacks)
09:05AM	CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell? (Zacks)
09:04AM	DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval (Zacks)
Mar-26-25 07:17AM	DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor (Zacks)
06:33AM	BDX Stock Declines Following Class I Classification for Alaris Recall (Zacks)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mauch Robert P.	President & CEO	May 19 '25	Option Exercise	86.09	3,225	277,640	50,807	May 21 04:04 PM
Mauch Robert P.	President & CEO	May 19 '25	Sale	291.43	4,969	1,448,116	45,838	May 21 04:04 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Option Exercise	86.09	12,578	1,082,840	328,491	May 21 04:00 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Sale	293.84	14,578	4,283,600	313,913	May 21 04:00 PM
COLLIS STEVEN H	Director	May 20 '25	Proposed Sale	293.84	14,578	4,283,600		May 20 09:45 AM
Hopfield Jessica	Member of immediate family of	May 19 '25	Proposed Sale	293.24	12,185	3,573,163		May 19 02:29 PM
Mauch Robert P.	Officer	May 19 '25	Proposed Sale	291.43	4,969	1,448,116		May 19 09:51 AM
GREENBERG LON R	Director	May 14 '25	Sale	279.05	3,000	837,150	17,851	May 16 04:23 PM
GREENBERG LON R	Director	May 14 '25	Proposed Sale	279.05	3,000	837,150		May 14 03:53 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Option Exercise	86.09	12,579	1,082,926	330,492	Apr 23 04:24 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Sale	281.81	14,579	4,108,508	315,913	Apr 23 04:24 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Option Exercise	86.09	3,225	277,640	52,551	Apr 22 04:06 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Sale	289.33	4,969	1,437,681	47,582	Apr 22 04:06 PM
COLLIS STEVEN H	Director	Apr 22 '25	Proposed Sale	281.81	14,579	4,108,508		Apr 22 09:42 AM
Mauch Robert P.	Officer	Apr 21 '25	Proposed Sale	289.33	4,969	1,437,681		Apr 21 09:48 AM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM
Walgreens Boots Alliance, Inc.	10% Owner	Feb 06 '25	Sale	244.51	1,286,376	314,531,796	12,570,000	Feb 10 07:35 PM
Walgreens Boots Alliance Holdi	Affiliate	Feb 06 '25	Proposed Sale	246.13	1,081,885	266,284,355		Feb 06 07:55 PM
Battaglia Silvana	Executive Vice President	Dec 20 '24	Sale	228.72	1,678	383,792	20,329	Dec 23 03:47 PM
Battaglia Silvana	Officer	Dec 20 '24	Proposed Sale	228.72	1,678	383,792		Dec 20 01:48 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 03 '24	Sale	250.41	1,816	454,754	21,988	Dec 04 04:22 PM
Krikorian Lazarus	Officer	Dec 03 '24	Proposed Sale	250.42	1,816	454,754		Dec 03 11:13 AM
Cleary James F	Chief Financial Officer	Nov 27 '24	Option Exercise	89.58	33,877	3,034,702	171,508	Dec 02 04:01 PM
COLLIS STEVEN H	Executive Chairman	Nov 25 '24	Sale	243.97	50,000	12,198,750	326,557	Nov 26 04:31 PM
COLLIS STEVEN H	Director	Nov 25 '24	Proposed Sale	243.98	50,000	12,198,760		Nov 25 04:04 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Option Exercise	89.58	21,509	1,926,776	328,261	Nov 21 04:49 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Sale	242.16	21,509	5,208,619	306,752	Nov 21 04:49 PM
COLLIS STEVEN H	Director	Nov 19 '24	Proposed Sale	242.16	21,509	5,208,619		Nov 19 10:00 AM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Oct 23 04:06 PM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Sale	235.80	21,509	5,071,822	285,088	Oct 23 04:06 PM
COLLIS STEVEN H	Officer	Oct 22 '24	Proposed Sale	235.80	21,509	5,071,822		Oct 22 10:43 AM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Sep 18 04:37 PM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Sale	241.01	21,509	5,183,884	285,088	Sep 18 04:37 PM
Lon Greenberg	Other: Board	Sep 17 '24	Proposed Sale	239.88	4,000	959,520		Sep 17 05:27 PM
COLLIS STEVEN H	Officer	Sep 17 '24	Proposed Sale	241.01	21,509	5,183,884		Sep 17 09:36 AM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Option Exercise	89.58	10,754	963,343	295,842	Aug 21 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Sale	239.13	10,754	2,571,604	285,088	Aug 21 04:08 PM
COLLIS STEVEN H	Officer	Aug 20 '24	Proposed Sale	239.13	10,754	2,571,604		Aug 20 10:47 AM
Battaglia Silvana	Executive Vice President	Aug 06 '24	Sale	242.69	1,473	357,482	10,948	Aug 07 04:09 PM
Battaglia Silvana	Officer	Aug 06 '24	Proposed Sale	242.69	1,473	357,483		Aug 06 02:08 PM
Walgreens Boots Alliance, Inc.	10% Owner	Aug 01 '24	Sale	240.56	4,438,171	1,067,646,416	19,980,000	Aug 05 06:44 PM
Walgreens Boots Alliance Holdi	Affiliate	Aug 01 '24	Proposed Sale	244.46	3,398,929	830,902,183		Aug 01 08:56 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Option Exercise	89.58	10,755	963,433	295,843	Jul 17 04:09 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Sale	222.12	10,755	2,388,901	285,088	Jul 17 04:09 PM
Donato Leslie E	EVP & Chief Strategy Officer	Jul 01 '24	Option Exercise	0.00	1,432	0	9,991	Jul 02 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Jun 18 '24	Option Exercise	89.58	10,754	963,343	295,842	Jun 20 04:16 PM
COLLIS STEVEN H	Chairman, President & CEO	Jun 18 '24	Sale	235.76	10,754	2,535,363	285,088	Jun 20 04:16 PM
Clark Gina	Executive Vice President	May 31 '24	Sale	223.86	1,874	419,506	13,284	Jun 03 04:05 PM
Clark Gina	Executive Vice President	May 29 '24	Option Exercise	86.09	27,093	2,332,436	42,251	May 31 04:00 PM
Clark Gina	Executive Vice President	May 29 '24	Sale	216.07	27,093	5,853,985	15,158	May 31 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COR

Cencora Inc

Upgrade your FINVIZ experience